Sutro Biopharma (STRO) Enterprise Value Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sutro Biopharma | 242.87 Mn | 242.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55.37% |
| Sep 30, 2025 | 56.83% |
| Jun 30, 2025 | -45.26% |
| Mar 31, 2025 | 6.96% |
| Dec 31, 2024 | -184.96% |
| Sep 30, 2024 | -20.91% |
| Jun 30, 2024 | 47.40% |
| Mar 31, 2024 | -6.42% |
| Dec 31, 2023 | 63.22% |
| Sep 30, 2023 | -140.19% |
| Jun 30, 2023 | -137.30% |
| Mar 31, 2023 | -46.71% |
| Dec 31, 2022 | -88.08% |
| Sep 30, 2022 | 29.61% |
| Jun 30, 2022 | -23.40% |
| Mar 31, 2022 | 22.19% |
| Dec 31, 2021 | 50.76% |
| Sep 30, 2021 | -32.60% |
| Jun 30, 2021 | 54.47% |
| Mar 31, 2021 | -90.89% |
| Dec 31, 2020 | -177.01% |
| Sep 30, 2020 | -14.44% |
| Jun 30, 2020 | -31.47% |
| Mar 31, 2020 | 32.35% |
| Dec 31, 2019 | 42.36% |
| Sep 30, 2019 | -1.80% |
| Jun 30, 2019 | -502.18% |
| Mar 31, 2019 | -2,466.11% |
| Dec 31, 2018 | -828.66% |
| Sep 30, 2018 | -383.64% |
| Dec 31, 2017 | -85.54% |